Damien McDonald

Insider profile

Currently holds positions in LivaNova PLC and Avita Medical Ltd

Performance

Overall performance
0.9

Performance over holding periods
0.9
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chief Executive Officer, Director LivaNova PLC Jan. 1, 2017 -
Non-Executive Director Avita Medical Ltd Jan. 13, 2016 -
Chief Operating Officer LivaNova PLC Oct. 3, 2016 - Dec. 31, 2016

Damien McDonald's trades of Enovis Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
183.39
Quantity 13,672 -43.2%
Value US$3,785,000
Transaction date
Purchase
Price
180.03
Quantity 25,632 -25.3%
Value US$4,251,391
Transaction date
Proposed sale
Price
311.38
Quantity 84,521
Value US$1,250,501
Transaction date
Proposed sale
Price
51.13
Quantity 8,847
Value US$452,319
Transaction date
Proposed sale
Price
48.49
Quantity 2,220
Value US$107,648
Transaction date
Planned sale
Price
42.55
Quantity 2,220 -1.9%
Value US$94,461
Transaction date
Planned sale
Price
54.56
Quantity 2,220 -2.6%
Value US$121,123
Transaction date
Planned sale
Price
81.50
Quantity 2,784 -3.6%
Value US$226,896
Transaction date
Planned sale
Price
68.00
Quantity 1,000 -1.5%
Value US$68,000
Transaction date
Planned sale
Price
75.68
Quantity 1,000 -1.5%
Value US$75,680
Transaction date
Planned sale
Price
74.40
Quantity 1,000 -1.7%
Value US$74,400
Transaction date
Planned sale
Price
73.82
Quantity 1,000 -1.6%
Value US$73,820
Transaction date
Planned sale
Price
77.00
Quantity 1,000 -1.6%
Value US$77,000
Transaction date
Planned sale
Price
72.60
Quantity 1,000 -1.6%
Value US$72,600
Transaction date
Planned sale
Price
73.58
Quantity 1,000 -1.5%
Value US$73,580
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-04 2026-09-04 B Purchase
13,672 -43.2%
183.39
US$3,785,000
13,672 -43.2% 183.39 US$3,785,000
2025-09-11 2025-09-11 B Purchase
25,632 -25.3%
180.03
US$4,251,391
25,632 -25.3% 180.03 US$4,251,391
2023-06-23 2023-06-23 PrS Proposed sale
84,521
311.38
US$1,250,501
84,521 311.38 US$1,250,501
2023-06-20 2023-06-20 PrS Proposed sale
8,847
51.13
US$452,319
8,847 51.13 US$452,319
2023-06-15 2023-06-15 PrS Proposed sale
2,220
48.49
US$107,648
2,220 48.49 US$107,648
2023-04-28 2023-03-30 PlS Planned sale
2,220 -1.9%
42.55
US$94,461
2,220 -1.9% 42.55 US$94,461
2022-12-19 2022-12-15 PlS Planned sale
2,220 -2.6%
54.56
US$121,123
2,220 -2.6% 54.56 US$121,123
2021-12-15 2021-12-13 PlS Planned sale
2,784 -3.6%
81.50
US$226,896
2,784 -3.6% 81.50 US$226,896
2020-02-05 2020-02-03 PlS Planned sale
1,000 -1.5%
68.00
US$68,000
1,000 -1.5% 68.00 US$68,000
2020-01-03 2020-01-02 PlS Planned sale
1,000 -1.5%
75.68
US$75,680
1,000 -1.5% 75.68 US$75,680
2019-11-05 2019-11-01 PlS Planned sale
1,000 -1.7%
74.40
US$74,400
1,000 -1.7% 74.40 US$74,400
2019-10-03 2019-10-01 PlS Planned sale
1,000 -1.6%
73.82
US$73,820
1,000 -1.6% 73.82 US$73,820
2019-09-05 2019-09-03 PlS Planned sale
1,000 -1.6%
77.00
US$77,000
1,000 -1.6% 77.00 US$77,000
2019-07-02 2019-07-01 PlS Planned sale
1,000 -1.6%
72.60
US$72,600
1,000 -1.6% 72.60 US$72,600
2019-06-07 2019-06-05 PlS Planned sale
1,000 -1.5%
73.58
US$73,580
1,000 -1.5% 73.58 US$73,580